• landaulabnyu

New Paper in Press!

Updated: Nov 10, 2020


Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice

Thomas D. Norton1,2*, Anjie Zhen3*, Takuya Tada1, Jennifer Kim3, Scott Kitchen3*, Nathaniel R. Landau2 In press.  Molecular Therapy.


Norton et al. (2019) report on a gene therapy-based therapeutic dendritic cell vaccine for HIV. The vaccine stimulated a strong HIV-specific CD8 T cell response that suppressed virus load by 100-fold in a humanized mouse model. The approach uses lentiviral vectors that activate dendritic cells and block checkpoint activation.



45 views0 comments

Prof. Nathaniel R. Landau, PhD

 

Professor, Department of Microbiology

 

Member of the Microbial Pathogenesis Program

Full Bio.

Department of Microbiology

Alexandria Center for Life Science - West Tower

430 East 29th Street
Office Rm. 509, Lab Rm. 524
New York, NY 10016

Nathaniel.Landau@nyulangone.org


Direct Line: (212) 263-9197
Fax: (646) 501-4645

  • Twitter Social Icon

©2019 Landau Lab - Biomedical Research Lab at NYU - New York City